The tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1

Medicine

Press/Media: Research

PeriodNov 2 2021

Media coverage

1

Media coverage

  • TitleThe tumor suppressor activity of DLC1 requires the interaction of its START domain with Phosphatidylserine, PLCD1, and Caveolin-1
    Media name/outletMOLECULAR CANCER
    Country/TerritoryUnited Kingdom
    Date11/2/21
    PersonsGregory D. Fairn
View all 1
View less